This report documents the principal results of a Conceptual Design Study for the Superconducting Toroidal Field System for a Tokamak Experimental Power Reactor. Two concepts are described for peak operating fields at the windings of 8 tesla, and 12 tesla, respectively. The design and manufacturing considerations are treated in sufficient detail that cost and schedule estimates could be developed. Major uncertainties in the design are identified and their potential impact discussed, along with recommendations for the necessary research and development programs to minimize these uncertainties. The minimum dimensions of a sub-size test coil for experimental qualification of the full size design are developed and a test program is recommended.

The analytical methods developed or adopted for use in support of radiochemistry and gamma ray spectroscopy, HTGR fuel reprocessing, HTGR fuel development, TRIGA fuel fabrication, and miscellaneous projects are reported. (JSR)

Computer programs were written to design and simulate the behavior of three heat exchangers for cooling supercritical helium to approximately 4.3/sup 0/K at 4 atm. Helium, at 1, 3, or 5 gm/sec, is cooled by passing it through 0.635-cm-diam copper tubing immersed in a liquid nitrogen bath, through a copper, concentric tube, counter-current heat exchanger, and then through 0.635-cm copper tubing immersed in a liquid helium bath. The helium then enters a superconducting test magnet and finally passes through the annulus of the countercurrent exchanger before venting to the atmosphere. Several acceptable designs are presented that meet design and space limitations.

Reports of tetracycline accumulation in human and animal tumors have led a number of investigators to postulate that this drug, if radio-labeled, might have potential as a therapeutic or diagnostic agent. This paper describes attempts to investigate this potential for tritiated tetracycling. The therapeutic studies demonstrated that while a significant reduction in the growth rates of transplanted tumors could be obtained by the administration of heavy doses of TTC relative to uninjected controls, similar reductions were observed in the growth rates of tumors in animals receiving unlabeled TC. In the localization studies in rodents, the concentrations of TTC in normal tissues and tumors were compared and were correlated with the corresponding concentrations of /sup 14/C-thymidine, a measure of proliferative activity.